Name | Value |
---|---|
Revenues | 636.3M |
Cost of Revenue | 412.8M |
Gross Profit | 223.5M |
Operating Expense | 253.8M |
Operating I/L | -30.3M |
Other Income/Expense | -45.4M |
Interest Income | 0.5M |
Pretax | -162.9M |
Income Tax Expense | -15.2M |
Net Income/Loss | -147.7M |
QuidelOrtho Corporation specializes in the development and manufacturing of diagnostic testing technologies for healthcare needs. The company's business units include Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics, offering a range of clinical chemistry and immunoassay laboratory instruments and tests, as well as rapid point-of-care testing solutions. They also provide blood typing and donor screening instruments for transfusion medicine, and molecular diagnostics equipment. QuidelOrtho sells its products directly and through distributors to various healthcare facilities and professionals, including physician offices, hospitals, clinical laboratories, and retail clinics, catering to both professional and non-professional use.